Hepatitis C Information Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

Hep C information
Free Newsletter
Hepatitis C Newsletter
We value your privacy. We will not rent your email to anyone.
HEPATITIS NEWS
The top stories compiled from over 5,500 sources, updated every 15 minutes

New Model Allows Testing of Hepatitis C Treatments
'This is the first efficient and consistent model system for HCV to be developed,' Martina Buck, assistant professor of medicine at the University of California, San Diego, School of Medicine, who developed the culture, said in a university news release.

Natalie Cole Says She Has Hepatitis C
NEW YORK (AP) - Grammy-winning singer Natalie Cole has been diagnosed with hepatitis C, her publicist said in a statement Wednesday. Hepatitis C is a liver disease spread through contact with infected blood. The statement said the disease was revealed

Natalie Cole says she has hepatitis C (07/17/2008)
Grammy-winning singer Natalie Cole has been diagnosed with hepatitis C, her publicist said in a statement yesterday. Hepatitis C is a liver disease spread through contact with infected blood. The statement said the disease was revealed during a routine

UPDATES AND COMMENTARY RSS Feed

Hep C and Fatty Liver Disease Linked by Enzyme
Pittsburgh researchers have found that an enzyme known to participate in fat production is elevated in those with Hepatitis C. Further exploration of this enzyme could help physicians better predict which HCV patients are at risk of developing fatty liver...

ANA773 Resumes Race Against Hepatitis C
By reducing the dosing schedule in half, Anadys Pharmaceuticals returns to their investigation of ANA773, a Toll-Like Receptor-7 agonist prodrug. Approaching the Hepatitis C virus differently from most other contenders, Phase I clinical trials evaluating the safety, tolerability and viral-load...

Popular Illegal Drug Extra Harmful with HCV
Although scores of Americans are turning to the street drug methamphetamine to keep them awake and thin, scientists have found that it worsens Hepatitis C infection in two worrisome ways....

University of Iowa Family Practice Handbook, 3rd Edition, Chapter 4

Gastroenterology: Ascites

Peter P. Toth, M.D., Ph.D.
Department of Family Medicine
University of Iowa
Peer Review Status: Externally Peer Reviewed by Mosby

  1. Ascites is a pathologic accumulation of serous fluid within the abdomen. It may be caused by decompensated liver disease (alcohol- and virus-related cirrhosis), heart failure, abdominal carcinomatosis, tuberculosis, and pancreatic disease. Cirrhosis is the cause for the most number of cases of ascites.
  2. Diagnostic paracentesis can confirm the diagnosis of portal hypertension or rule out the possibility of infection. The following tests should be performed on ascites fluid: cell count, cytology, culture (in blood culture bottles), Gram stain, total protein, glucose, lactate dehydrogenase, amylase, and, if warranted, mycobacterial smear and culture. Samples with   Less Than250 neutrophils per milliliter are assumed to be infected, and broad-spectrum antibiotic therapy should be initiated. Patients with a total protein concentration Less Than1.0 g/dl are at high risk for spontaneous bacterial peritonitis. There is good evidence that Bactrim (1 DS tablet daily 5 days a week) is effective in preventing spontaneous bacterial peritonitis and decreasing mortality. Norfloxacin has been used as well, but its use is discouraged because of the rapid development of resistant organisms.
  3. Therapeutic paracentesis with the removal of 5 or moreLiters is indicated if the patient presents with early satiety or shortness of breath. After the procedure, give 40 g of albumin IV to prevent hyponatremia and renal failure.
  4. The serum-ascites albumin gradient is equal to [albumin]serum - [albumin]ascites. If the gradient exceeds 1.1 g/dl, the patient has portal hypertension.
  5. Treatment consists in restricting sodium intake and the promotion of natriuresis with oral diuretics. Combinations of furosemide and spironolactone have been shown to be optimal for promoting sodium excretion and sparing potassium. Doses should be titrated to a maximum of 400 mg/day and 160 mg/day of spironolactone and furosemide respectively. Serial determinations of urinary sodium excretion may help to guide dosing. Other therapies include portal shunting and liver transplantation. Overaggressive diuresis is associated with hepatorenal syndrome (a relatively acute, progressive renal failure in the patient with advanced liver disease secondary to decreased renal perfusion) and is discouraged. Large-volume paracentesis is preferable.

    table Of Contents

  Hep C information

Information at this website is for educational purposes only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.

©1994-2008 Hepatitis-Central.com
Updated 19 Jul 2008